M. Schweigert

A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry.

H. Tesch, A. Tsamaloukas, U. Totzke, 2011, European journal of cancer care.

Safe adalimumab therapy for rheumatoid arthritis in a patient with pre-existing multiple myeloma

M. Schweigert, F. Mielke, 2008, Nature Clinical Practice Rheumatology.

Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

O. Sezer, K. Possinger, P. Schmid, 2005, Investigational New Drugs.

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors.

S Seeber, C. Unger, D. Strumberg, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study

K. Possinger, J. Schanz, I. Genvresse, 2001, Anti-cancer drugs.

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia--examination of practice in Germany.

H. Tesch, S. Schmitz, A. Tsamaloukas, 2008, Current Medical Research and Opinion.

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia – examination of practice in Germany

H. Tesch, A. Tsamaloukas, U. Totzke, 2008 .